

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.81%
-0.29%
-4.39%
-2.79%
-27.97%
CL
Colgate-Palmolive Company
$77.05
Strengths

Upgraded on attractively valued

Outperform the market
Risk Analysis

Earnings are forecast to decrease
Chart
$77.45 (-0.52%)
$84.69 (-9.02%)
$92.11 (-16.35%)
$91.45 (-15.75%)
CL has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

CL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue declined YoY

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

Outperform the market
![]()
CL Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CL Street view is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CL current stock price?
What are CL stock strengths?
What risks are associated with CL stock?
When is CL next earnings report?
What is CL market cap and volume?
What is CL's current Stock IQ?
Should I buy CL stock right now?
Is CL a Strong Buy right now?
What does a 'Strong Buy' rating mean for CL?
What does a 'Strong Sell' rating mean for CL?
What factors influence CL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.81%
-0.29%
-4.39%
-2.79%
-27.97%
CL
Colgate-Palmolive Company
Current Price
$77.05
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
Risk Analysis

Earnings are forecast to decrease
Chart
$77.45 (-0.52%)
$84.69 (-9.02%)
$92.11 (-16.35%)
$91.45 (-15.75%)
CL Analysts Opinion
CL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue declined YoY

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease

Outperform the market
![]()
CL Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CL Street view is unimpressive and have negative views on the near-term outlook
CL has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels.
CL Latest Analysis
Earnings Snapshot: Colgate-Palmolive beats Q3 profit sees FY net sales up low single digits.
Today
Colgate-Palmolive (CL) Surpasses Q3 Earnings Estimates. Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.25% and -0.07% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Today
Colgate-Palmolive Co. Q3 Profit Beats Estimates . (RTTNews) - Colgate-Palmolive Co. (CL) revealed a profit for third quarter that beat the Street estimates.
Today
Colgate-Palmolive Reaffirms FY25 EPS Adj. EPS And Organic Sales Growth Outlook - Update . (RTTNews) - While reporting financial results for the third quarter on Friday Colgate-Palmolive Co. (CL) reaffirms earnings adjusted earnings net sales growth guidance for the full-year 2025 while trimming organic sales growth outlook.
Today
Colgates Pre-Q3 Earnings: Will Pricing Actions Offset Cost Headwinds?. CLs Q3 results are likely to reveal how pricing strength and productivity gains help offset inflation currency pressures and regional softness.
Tue Oct 28, 2025
Analysts Estimate Colgate-Palmolive (CL) to Report a Decline in Earnings: What to Look Out for. Colgate-Palmolive (CL) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fri Oct 24, 2025
Colgate-Palmolive shares slide 4% after Q2 profit falls 17% YoY brokerages trim target price . In a challenging turn of events Colgate-Palmolive Indias shares took a hit as the company reported a 17% decline in net profit for the September quarter alongside a drop in revenue. The decline was attributed to recent changes in the Goods and Services Tax rates affecting oral care products.
Fri Oct 24, 2025
Stocks in news: ITC Hotels Dr Reddys SBI Life Hero MotoCorp Vedanta . Markets traded volatile on Thursday ending nearly unchanged after early gains were erased by profit-taking in heavyweight stocks. Analysts suggest a short-term consolidation phase is likely with Nifty holding above 25600 considered healthy. Several companies including Vedanta Hero MotoCorp and Colgate-Palmolive are in focus due to investment plans international expansion and Q2 results.
Thu Oct 23, 2025
Colgate-Palmolive Q2 Results: PAT falls 17% YoY revenue down 6% on GST transition. Check dividend . Colgate-Palmolive India reported Q2 net profit at Rs 328 crore down 17% YoY with revenue falling 6% to Rs 1507 crore due to GST rate cuts on oral care products. GST on the companys entire oral care portfolio was reduced from 18% to 5%.
Thu Oct 23, 2025
Raymond James Maintains Colgate-Palmolive (CL) Outperform Recommendation. Fintel reports that on October 20 2025 Raymond James maintained coverage of Colgate-Palmolive (NYSE:CL) with a Outperform recommendation. Analyst Price Forecast Suggests 22.46% Upside
Tue Oct 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.